Breaking News Instant updates and real-time market news.

10:25
03/05/20
03/05
10:25
03/05/20
10:25

Guggenheim utilities analysts to hold an analyst/industry conference call

Utilities Analysts, along with Jon Wellinghoff, CEO of GridPolicy, discuss the outlook for several policy initiatives at FERC on an Analyst/Industry conference call to be held on March 5 at 11 am.

TODAY'S FREE FLY STORIES

Upgrade
Energias de Portugal upgraded to Buy from Hold at Societe Generale » 05:21
03/05/21
03/05
05:21
03/05/21
05:21
EDPFY

Energias de Portugal

$0.00 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EDPFY Energias de Portugal
$0.00 /

+ (+0.00%)

01/20/21 Morgan Stanley
Energias de Portugal resumed with an Overweight at Morgan Stanley
09/21/20 RBC Capital
Energias de Portugal upgraded to Sector Perform at RBC Capital
09/16/20 Credit Suisse
Energias de Portugal price target raised to EUR 5 at Credit Suisse
08/28/20 JPMorgan
Energias de Portugal price target raised to EUR 4.65 from EUR 4.50 at JPMorgan
Downgrade
Roche downgraded to Hold from Buy at Erste Group » 05:20
03/05/21
03/05
05:20
03/05/21
05:20
RHHBY

Roche

$0.00 /

+ (+0.00%)

Erste Group analyst Hans…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

03/03/21 Goldman Sachs
Adaptive Biotechnologies downgraded to Neutral from Buy at Goldman Sachs
02/25/21 Berenberg
Roche price target lowered to CHF 320 from CHF 325 at Berenberg
02/24/21 Morgan Stanley
Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Upgrade
Amadeus IT Group upgraded to Buy from Hold at Erste Group » 05:20
03/05/21
03/05
05:20
03/05/21
05:20
AMADY

Amadeus IT Group

$0.00 /

+ (+0.00%)

Erste Group analyst Hans…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMADY Amadeus IT Group
$0.00 /

+ (+0.00%)

AMADY Amadeus IT Group
$0.00 /

+ (+0.00%)

03/02/21 UBS
Amadeus IT Group price target lowered to EUR 61 from EUR 65 at UBS
03/01/21 JPMorgan
Amadeus IT Group price target raised to EUR 58 from EUR 50 at JPMorgan
03/01/21 Oddo BHF
Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF
03/01/21 Oddo BHF
Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF
Initiation
Cadeler initiated with a Buy at Kepler Cheuvreux » 05:19
03/05/21
03/05
05:19
03/05/21
05:19
CADLF

Cadeler

$0.00 /

+ (+0.00%)

Kepler Cheuvreux…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CADLF Cadeler
$0.00 /

+ (+0.00%)

01/06/21 DNB Markets
Cadeler initiated with a Buy at DNB Markets
Earnings
GSX Techedu reports Q4 EPS (39c), consensus (38c) » 05:19
03/05/21
03/05
05:19
03/05/21
05:19
GSX

GSX Techedu

$84.11 /

-2.9 (-3.33%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSX GSX Techedu
$84.11 /

-2.9 (-3.33%)

GSX GSX Techedu
$84.11 /

-2.9 (-3.33%)

02/01/21 JPMorgan
GSX Techedu downgraded to Underweight from Neutral at JPMorgan
01/29/21
GSX Techedu downgraded to Sell from Neutral at China Merchants
01/28/21 Goldman Sachs
GSX Techedu downgraded to Sell from Neutral at Goldman Sachs
12/17/20
Fly Intel: Top five analyst downgrades
GSX GSX Techedu
$84.11 /

-2.9 (-3.33%)

GSX GSX Techedu
$84.11 /

-2.9 (-3.33%)

GSX GSX Techedu
$84.11 /

-2.9 (-3.33%)

GSX GSX Techedu
$84.11 /

-2.9 (-3.33%)

Upgrade
AXA upgraded to Conviction Buy from Buy at Bryan Garnier » 05:19
03/05/21
03/05
05:19
03/05/21
05:19
AXAHY

AXA

$0.00 /

+ (+0.00%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXAHY AXA
$0.00 /

+ (+0.00%)

03/03/21 Deutsche Bank
AXA price target raised to EUR 25 from EUR 24.50 at Deutsche Bank
03/02/21 Morgan Stanley
AXA price target lowered to EUR 24 from EUR 24.20 at Morgan Stanley
03/01/21 Berenberg
AXA price target raised to EUR 23.30 from EUR 21.50 at Berenberg
02/26/21 RBC Capital
AXA price target raised to EUR 24 from EUR 23 at RBC Capital
AXAHY AXA
$0.00 /

+ (+0.00%)

Upgrade
Meggitt upgraded to Outperform from Neutral at Exane BNP Paribas » 05:18
03/05/21
03/05
05:18
03/05/21
05:18
MEGGF

Meggitt

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEGGF Meggitt
$0.00 /

+ (+0.00%)

02/11/21 Morgan Stanley
Meggitt price target lowered to 455 GBp from 465 GBp at Morgan Stanley
02/04/21 Jefferies
Meggitt price target raised to 500 GBp from 375 GBp at Jefferies
01/08/21 JPMorgan
Meggitt price target lowered to 390 GBp from 395 GBp at JPMorgan
12/15/20 Panmure Gordon
Meggitt downgraded to Sell from Hold at Panmure Gordon
Upgrade
Woodside Petroleum upgraded to Overweight from Neutral at JPMorgan » 05:17
03/05/21
03/05
05:17
03/05/21
05:17
WOPEY

Woodside Petroleum

$0.00 /

+ (+0.00%)

JPMorgan analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WOPEY Woodside Petroleum
$0.00 /

+ (+0.00%)

12/09/20 JPMorgan
Woodside Petroleum downgraded to Neutral from Overweight at JPMorgan
07/17/20 Citi
Woodside Petroleum downgraded to Neutral from Buy at Citi
06/25/20 JPMorgan
Woodside Petroleum upgraded to Overweight from Neutral at JPMorgan
05/05/20 Bernstein
Woodside Petroleum upgraded to Outperform from Market Perform at Bernstein
Downgrade
Brembo downgraded to Reduce from Hold at Kepler Cheuvreux » 05:16
03/05/21
03/05
05:16
03/05/21
05:16
BRBOF

Brembo

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRBOF Brembo
$0.00 /

+ (+0.00%)

02/01/21 Exane BNP Paribas
Brembo downgraded to Underperform from Neutral at Exane BNP Paribas
Upgrade
Belimo Holding upgraded to Hold from Reduce at Kepler Cheuvreux » 05:15
03/05/21
03/05
05:15
03/05/21
05:15
BLHWF

Belimo Holding

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLHWF Belimo Holding
$0.00 /

+ (+0.00%)

12/11/20 Berenberg
Belimo Holding price target raised to CHF 8,250 from CHF 8,000 at Berenberg
05/26/20 UBS
Belimo Holding price target lowered to CHF 5,150 from CHF 5,200 at UBS
03/18/20 Berenberg
Belimo Holding upgraded to Buy from Hold at Berenberg
Earnings
ObsEva reports Q4 EPS (32c), consensus (42c) » 05:15
03/05/21
03/05
05:15
03/05/21
05:15
OBSV

ObsEva

$3.37 /

-0.32 (-8.67%)

As of December 31, 2020,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OBSV ObsEva
$3.37 /

-0.32 (-8.67%)

OBSV ObsEva
$3.37 /

-0.32 (-8.67%)

01/04/21 H.C. Wainwright
ObsEva price target lowered to $17 from $23 at H.C. Wainwright
11/09/20 JPMorgan
ObsEva downgraded to Underweight from Neutral at JPMorgan
10/05/20 H.C. Wainwright
ObsEva price target lowered to $23 from $36 at H.C. Wainwright
07/07/20 Wedbush
Selloff in ObsEva shares 'overdone,' says Wedbush
OBSV ObsEva
$3.37 /

-0.32 (-8.67%)

  • 30
    Oct
OBSV ObsEva
$3.37 /

-0.32 (-8.67%)

OBSV ObsEva
$3.37 /

-0.32 (-8.67%)

Initiation
Technip Energies initiated with a Buy at Kepler Cheuvreux » 05:15
03/05/21
03/05
05:15
03/05/21
05:15
THNPF

Technip Energies

$0.00 /

+ (+0.00%)

Kepler Cheuvreux…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THNPF Technip Energies
$0.00 /

+ (+0.00%)

03/01/21 Exane BNP Paribas
Technip Energies initiated with a Neutral at Exane BNP Paribas
03/01/21 Morgan Stanley
Technip Energies initiated with an Overweight at Morgan Stanley
02/22/21 Barclays
Technip Energies initiated with an Equal Weight at Barclays
Upgrade
Barclays upgraded to Add from Sell at AlphaValue » 05:14
03/05/21
03/05
05:14
03/05/21
05:14
BCS

Barclays

$9.21 /

-0.235 (-2.49%)

AlphaValue upgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCS Barclays
$9.21 /

-0.235 (-2.49%)

BCS Barclays
$9.21 /

-0.235 (-2.49%)

02/23/21 JPMorgan
Barclays price target raised to 190 GBp from 180 GBp at JPMorgan
02/22/21 RBC Capital
Barclays price target raised to 150 GBp from 140 GBp at RBC Capital
02/19/21 Deutsche Bank
Barclays price target raised to 200 GBp from 180 GBp at Deutsche Bank
01/28/21 Berenberg
Barclays price target raised to 180 GBp from 160 GBp at Berenberg
BCS Barclays
$9.21 /

-0.235 (-2.49%)

BCS Barclays
$9.21 /

-0.235 (-2.49%)

BCS Barclays
$9.21 /

-0.235 (-2.49%)

BCS Barclays
$9.21 /

-0.235 (-2.49%)

Upgrade
Henkel upgraded to Hold from Sell at Nord/LB » 05:13
03/05/21
03/05
05:13
03/05/21
05:13
HENKY

Henkel

$0.00 /

+ (+0.00%)

Nord/LB analyst Thorsten…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HENKY Henkel
$0.00 /

+ (+0.00%)

01/12/21 UBS
Henkel price target raised to EUR 81 from EUR 80 at UBS
01/05/21 Barclays
Barclays trims Henkel Adhesive estimates on slower recovery expectations
12/03/20 JPMorgan
Henkel upgraded to Overweight from Neutral at JPMorgan
11/30/20 Commerzbank
Henkel upgraded to Buy from Hold at Commerzbank
Hot Stocks
Moderna announces Takeda NDA submission to distribute COVID-19 vaccine in Japan » 05:12
03/05/21
03/05
05:12
03/05/21
05:12
MRNA

Moderna

$132.21 /

+1.01 (+0.77%)

, TAK

Takeda Pharmaceutical

$17.45 /

-0.25 (-1.41%)

Moderna (MRNA) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$132.21 /

+1.01 (+0.77%)

TAK Takeda Pharmaceutical
$17.45 /

-0.25 (-1.41%)

MRNA Moderna
$132.21 /

+1.01 (+0.77%)

03/01/21 Chardan
Moderna price target raised to $182 from $107 at Chardan
02/26/21 Barclays
Moderna price target raised to $178 from $169 at Barclays
02/26/21 Brookline
Moderna price target raised to $205 from $180 at Brookline
02/25/21 Piper Sandler
Moderna transitioning into profitable company, says Piper Sandler
TAK Takeda Pharmaceutical
$17.45 /

-0.25 (-1.41%)

03/03/21 RBC Capital
Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal
01/29/21 Morgan Stanley
Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout
12/29/20 Needham
Needham names Phathom Pharmaceuticals Top Pick for 2021
12/15/20 Needham
Phathom Pharmaceuticals price target raised to $55 from $45 at Needham
MRNA Moderna
$132.21 /

+1.01 (+0.77%)

  • 19
    May
MRNA Moderna
$132.21 /

+1.01 (+0.77%)

TAK Takeda Pharmaceutical
$17.45 /

-0.25 (-1.41%)

MRNA Moderna
$132.21 /

+1.01 (+0.77%)

TAK Takeda Pharmaceutical
$17.45 /

-0.25 (-1.41%)

MRNA Moderna
$132.21 /

+1.01 (+0.77%)

TAK Takeda Pharmaceutical
$17.45 /

-0.25 (-1.41%)

Recommendations
Costco price target lowered to $395 from $410 at Baird » 05:07
03/05/21
03/05
05:07
03/05/21
05:07
COST

Costco

$319.35 /

-4.53 (-1.40%)

Baird analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COST Costco
$319.35 /

-4.53 (-1.40%)

COST Costco
$319.35 /

-4.53 (-1.40%)

02/03/21 Baird
Costco January core comps re-accelerated, says Baird
02/02/21 Cleveland Research
Costco U.S. sales slightly improved in January, says Cleveland Research
01/07/21 Deutsche Bank
Costco price target raised to $347 from $344 at Deutsche Bank
01/06/21 Baird
Costco saw some deceleration in December core comp sales, says Baird
COST Costco
$319.35 /

-4.53 (-1.40%)

COST Costco
$319.35 /

-4.53 (-1.40%)

COST Costco
$319.35 /

-4.53 (-1.40%)

COST Costco
$319.35 /

-4.53 (-1.40%)

Hot Stocks
Daqo signs three-year, 52,700 MT polysilicon supply agreement with Shangji » 05:07
03/05/21
03/05
05:07
03/05/21
05:07
DQ

Daqo New Energy

$85.93 /

-8.76 (-9.25%)

Daqo New Energy announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DQ Daqo New Energy
$85.93 /

-8.76 (-9.25%)

DQ Daqo New Energy
$85.93 /

-8.76 (-9.25%)

03/02/21 Roth Capital
Daqo New Energy price target raised to $115 from $105 at Roth Capital
02/08/21 Roth Capital
Bill could be 'meaningful positive' for solar stocks, says Roth Capital
01/26/21 Roth Capital
Daqo New Energy price target raised to $100 from $40 at Roth Capital
12/21/20 Roth Capital
ITC/PTC extensions likely included in COVID relief package, says Roth Capital
DQ Daqo New Energy
$85.93 /

-8.76 (-9.25%)

DQ Daqo New Energy
$85.93 /

-8.76 (-9.25%)

DQ Daqo New Energy
$85.93 /

-8.76 (-9.25%)

Recommendations
Fulgent Genetics price target raised to $140 from $135 at Piper Sandler » 05:06
03/05/21
03/05
05:06
03/05/21
05:06
FLGT

Fulgent Genetics

$85.08 /

-7.3 (-7.90%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

02/03/21 Piper Sandler
Fulgent Genetics price target raised to $135 from $100 at Piper Sandler
02/01/21 Oppenheimer
Fulgent Genetics price target raised to $130 from $75 at Oppenheimer
02/01/21 Oppenheimer
Invitae downgraded to Perform on valuation at Oppenheimer
01/08/21 Credit Suisse
Fulgent Genetics downgraded to Underperform from Neutral at Credit Suisse
FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

FLGT Fulgent Genetics
$85.08 /

-7.3 (-7.90%)

Recommendations
Alphatec price target raised to $19 from $17 at Piper Sandler » 05:05
03/05/21
03/05
05:05
03/05/21
05:05
ATEC

Alphatec

$15.86 /

-0.69 (-4.17%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATEC Alphatec
$15.86 /

-0.69 (-4.17%)

ATEC Alphatec
$15.86 /

-0.69 (-4.17%)

01/29/21 Piper Sandler
Alphatec price target raised to $17 from $12 at Piper Sandler
01/12/21 Piper Sandler
Piper remains buyer of Alphatec despite Covid pressures
12/21/20 H.C. Wainwright
Alphatec price target raised to $16 from $12 at H.C. Wainwright
12/18/20 Lake Street
Alphatec price target raised to $20 from $15 at Lake Street
ATEC Alphatec
$15.86 /

-0.69 (-4.17%)

  • 14
    Oct
ATEC Alphatec
$15.86 /

-0.69 (-4.17%)

Upgrade
Bombardier upgraded to Outperform from Market Perform at BMO Capital » 05:04
03/05/21
03/05
05:04
03/05/21
05:04
BDRBF

Bombardier

$0.00 /

+ (+0.00%)

BMO Capital analyst Fadi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BDRBF Bombardier
$0.00 /

+ (+0.00%)

BDRBF Bombardier
$0.00 /

+ (+0.00%)

02/16/21 Cowen
Bombardier downgraded to Underperform from Market Perform at Cowen
02/16/21 Scotiabank
Bombardier price target raised to C$0.65 from C$0.55 at Scotiabank
02/12/21 National Bank
Bombardier price target lowered to C$0.70 from C$0.80 at National Bank
02/12/21 BMO Capital
Bombardier price target raised to C$0.85 from C$0.40 at BMO Capital
BDRBF Bombardier
$0.00 /

+ (+0.00%)

BDRBF Bombardier
$0.00 /

+ (+0.00%)

Recommendations
Cutera price target raised to $42 from $38 at Piper Sandler » 05:02
03/05/21
03/05
05:02
03/05/21
05:02
CUTR

Cutera

$26.21 /

-8.715 (-24.96%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CUTR Cutera
$26.21 /

-8.715 (-24.96%)

CUTR Cutera
$26.21 /

-8.715 (-24.96%)

02/18/21 Piper Sandler
Cutera price target raised to $38 from $28 at Piper Sandler
11/05/20 Piper Sandler
Cutera price target raised to $28 from $22 at Piper Sandler
09/14/20 Stephens
Cutera price target raised to $24 from $18 at Stephens
08/07/20 Piper Sandler
Cutera should be bought at these 'depressed levels,' says Piper Sandler
CUTR Cutera
$26.21 /

-8.715 (-24.96%)

  • 17
    Apr
CUTR Cutera
$26.21 /

-8.715 (-24.96%)

Upgrade
Fifth Third upgraded to Conviction Buy from Buy at Goldman Sachs » 05:00
03/05/21
03/05
05:00
03/05/21
05:00
FITB

Fifth Third

$35.57 /

-0.36 (-1.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FITB Fifth Third
$35.57 /

-0.36 (-1.00%)

FITB Fifth Third
$35.57 /

-0.36 (-1.00%)

02/17/21 Citi
Citi recommends two new U.S. bank pair trades
01/27/21 Argus
Fifth Third price target raised to $35 from $27 at Argus
01/22/21 Wedbush
Fifth Third price target raised to $39 from $36 at Wedbush
01/22/21 RBC Capital
Fifth Third price target raised to $32 from $27 at RBC Capital
FITB Fifth Third
$35.57 /

-0.36 (-1.00%)

FITB Fifth Third
$35.57 /

-0.36 (-1.00%)

FITB Fifth Third
$35.57 /

-0.36 (-1.00%)

Downgrade
Nikola downgraded to Neutral from Overweight at JPMorgan » 04:56
03/05/21
03/05
04:56
03/05/21
04:56
NKLA

Nikola

$16.04 /

-0.49 (-2.96%)

JPMorgan analyst Paul…

JPMorgan analyst Paul Coster downgraded Nikola to Neutral from Overweight with a price target of $30, down from $33. Following the Q4 report, which provided investors reassurance that the company is "more focused," much of "good news is now priced in the stock," Coster tells investors in a research note. The analyst believes the story "should heat up again" in to mid- to late-2021 if customer orders get announced and as the first fuel cell electric vehicle prototype "comes to life." Coster calls the downgrade a "tactical call" based on the timing of catalysts.

ShowHide Related Items >><<
NKLA Nikola
$16.04 /

-0.49 (-2.96%)

NKLA Nikola
$16.04 /

-0.49 (-2.96%)

02/01/21
Fly Intel: Top five analyst upgrades
02/01/21 Wedbush
Nikola upgraded to Neutral from Underperform at Wedbush
12/28/20 JPMorgan
JPMorgan cuts Nikola target but sees 'generally positive' news flow in 2021
12/24/20 Loop Capital
Nikola faces 'another setback in a series of setbacks,' says Loop Capital
NKLA Nikola
$16.04 /

-0.49 (-2.96%)

NKLA Nikola
$16.04 /

-0.49 (-2.96%)

NKLA Nikola
$16.04 /

-0.49 (-2.96%)

NKLA Nikola
$16.04 /

-0.49 (-2.96%)

Conference/Events
SeaSpine management to meet virtually with BTIG » 04:55
03/05/21
03/05
04:55
03/05/21
04:55
SPNE

SeaSpine

$17.86 /

-0.69 (-3.72%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPNE SeaSpine
$17.86 /

-0.69 (-3.72%)

SPNE SeaSpine
$17.86 /

-0.69 (-3.72%)

03/02/21 Canaccord
SeaSpine price target raised to $25 from $23 at Canaccord
03/01/21 Piper Sandler
SeaSpine price target raised to $28 from $22 at Piper Sandler
01/29/21 Piper Sandler
SeaSpine price target raised to $22 from $18 at Piper Sandler
01/11/21 Piper Sandler
SeaSpine should be bought on any weakness today, says Piper Sandler
SPNE SeaSpine
$17.86 /

-0.69 (-3.72%)

SPNE SeaSpine
$17.86 /

-0.69 (-3.72%)

Conference/Events
Zealand Pharma to host research and development virtual day » 04:55
03/05/21
03/05
04:55
03/05/21
04:55
ZEAL

Zealand Pharma

$30.87 /

-0.65 (-2.06%)

Research and Development…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
ZEAL Zealand Pharma
$30.87 /

-0.65 (-2.06%)

ZEAL Zealand Pharma
$30.87 /

-0.65 (-2.06%)

03/10/20 Morgan Stanley
Zealand Pharma EPS estimates cut at Morgan Stanley
ZEAL Zealand Pharma
$30.87 /

-0.65 (-2.06%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.